Dont Consume Too Much Caffeine While moderate caffeine intake is generally considered safe, individuals who consume large amounts of caffeine may want to be mindful of their glutathione levels and consider balancing their diet with foods rich in glutathione precursors, such as fruits and vegetables
Asif Baliyan is a doctor and clinical researcher with over a decade of experience in evidence-based diagnostic medicine
Q-Switched Nd: YAG laser breaks melanin into tiny fragments that the body gradually removes, leading to clearer, brighter skin
High-dose GHRP-6: Moderate-high risk Why it's concerning: Significant appetite increase (can derail diet) Prolactin elevation (gynecomastia risk in sensitive individuals) Cortisol increase at high doses Water retention When it might be acceptable: Moderate doses (100-200mcg, not 300+mcg) Short-term use (8-12 weeks) If appetite increase isn't problematic Safer alternatives: Ipamorelin (no prolactin/cortisol increase) Lower GHRP-6 doses with careful monitoring Hexarelin: Higher risk than benefits justify Why it's problematic: Rapid desensitization (must cycle frequently) Cortisol and prolactin elevation Heart stress concerns Diminishing returns Limited use cases: Very short cycles (4 weeks maximum) Experienced users only With careful monitoring Better options: Ipamorelin for sustained results GHRP-2 for middle ground Synthetic growth hormone: Highest overall risk Why avoid: Complete shutdown of natural GH production Organ growth (hands, feet, jaw, internal organs) Insulin resistance Expensive Requires PCT (post-cycle therapy) Legal issues in most countries Only justified for: Medical growth hormone deficiency Under physician supervision Replacement doses, not supraphysiological Much safer alternatives: CJC-1295 + Ipamorelin stack Natural peptides that stimulate endogenous GH No shutdown, no PCT needed See peptides vs steroids and peptides vs SARMs for safety comparisons
Selected Research References Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS
HOMA-IR equation was found to have limited accuracy in adults between the ages 60 and 88 and subjects on insulin treatment (unless the glucose and insulin are in steady-state levels in subjects on insulin) 79,80
